Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA places clinical hold on phase I/II study of SIG-001 in hemophilia A

July 12, 2021

Phase Ib extension data for belapectin plus Keytruda in melanoma and head and neck cancer

July 12, 2021

New protein O-GlcNAcase inhibitors discovered at Janssen Pharmaceutica

July 12, 2021

Sinovent patents CDK7/cyclin H inhibitors

July 12, 2021

Possible target LGALS3BP binds to SARS-CoV-2 spike glycoprotein

July 12, 2021

Results of phase I trial of CRAd-S-pk7 oncolytic adenovirus delivered by neural stem cells in glioma

July 12, 2021

GS-441524 is an effective antiviral against African swine fever virus in vitro

July 12, 2021

Pentadefenin hydrogel developed for treating vaginitis

July 12, 2021

New influenza A virus vaccine synthesized at the University of Gdansk

July 12, 2021

Shire Human Genetic Therapies describes IDS gene therapy

July 12, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...